This paper reviews hidradenitis suppurativa (HS) through the lens of basic and translational science, reframing the understanding of its pathophysiology and potential therapeutic targets.
The paper appears to be a review or perspective piece; no original clinical trial data or patient outcomes are reported, limiting direct evidence generation.
